Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447226
Status:
TERMINATED
Last Update Posted:
2012-06-12
First Post:
2007-03-13
Brief Title:
Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy or Where no Approved Therapy Exists
Sponsor:
Organization:
GlaxoSmithKline